These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8423907

  • 1. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators.
    Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC.
    Neurology; 1993 Jan; 43(1):32-6. PubMed ID: 8423907
    [Abstract] [Full Text] [Related]

  • 2. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.
    Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E.
    Cerebrovasc Dis; 2000 Jan; 10(1):39-43. PubMed ID: 10629345
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
    Miller VT, Pearce LA, Feinberg WM, Rothrock JF, Anderson DC, Hart RG.
    Neurology; 1996 Jan; 46(1):238-40. PubMed ID: 8559383
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
    Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW.
    Stroke; 1999 Jun; 30(6):1223-9. PubMed ID: 10356104
    [Abstract] [Full Text] [Related]

  • 5. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
    Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, Nasco E, Sherman DG, Talbert RL, Marler JR, Stroke Prevention in Atrial Fibrillation Investigators.
    Ann Intern Med; 2003 May 20; 138(10):831-8. PubMed ID: 12755555
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation.
    Naya T, Yukiiri K, Hosomi N, Takahashi T, Ohkita H, Mukai M, Koziol JA, Kohno M.
    Cerebrovasc Dis; 2008 May 20; 26(4):434-40. PubMed ID: 18799875
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preventing stroke in patients with atrial fibrillation.
    Ezekowitz MD, Levine JA.
    JAMA; 1999 May 19; 281(19):1830-5. PubMed ID: 10340371
    [Abstract] [Full Text] [Related]

  • 17. Progress report of the Stroke Prevention in Atrial Fibrillation Study.
    Anderson DC.
    Stroke; 1990 Nov 19; 21(11 Suppl):III12-7. PubMed ID: 2237968
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG, Gulløv AL, Petersen P.
    Nord Med; 1996 Jun 19; 111(6):171-5. PubMed ID: 8700641
    [Abstract] [Full Text] [Related]

  • 20. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb 26; 156(4):409-16. PubMed ID: 8607726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.